← Open Payments lookup

AUTUMN WORK: Open Payments

NPI 1275241051 · LINDSAY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$447 in 24 payments from 12 companies in 2025. Trend: 2023 $104 · 2024 $237 · 2025 $447

Food & beverage: $447
CompanyPaymentsAmount
Novo Nordisk Inc6$138
Lilly USA, LLC3$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
AstraZeneca Pharmaceuticals LP2$34
Bayer Healthcare Pharmaceuticals Inc.2$34
Sumitomo Pharma America, Inc.2$34
ABBVIE INC.2$31
Teva Pharmaceuticals USA, Inc.1$22
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Biogen, Inc.1$15

Products named: Ozempic, Rybelsus, MOUNJARO, CAPLYTA, BREZTRI, Kerendia, GEMTESA, VRAYLAR.

Industry payments across OK — which companies pay providers there.